Benefits of β-blockers in cancer treatment
نویسندگان
چکیده
Cancer is one of the leading causes death in world. Researchers keep attempting to develop therapy modalities decrease mortality and morbidity cancer patients by trying comprehend effect sympathetic nerves (through catecholamine adrenergic receptors) development. Catecholamine activation β-adrenergic receptors (β1-AR, β2-AR, β3-AR) may influence cytokine immunity system, initiate tumorigenesis, stimulate tumor-associated macrophage angiogenesis, tumor microenvironment, facilitate cell metastasis, increased progressivity cells. β-blockers inhibit on β-AR various types paths needed for cells develop. also apoptosis, pro-inflammatory mediators growth factors In addition, have benefits as supplementary therapy, increase chemoradiotherapy sensitivity, cardiotoxicity, improve cachexia. The are expected reduce survival rates patients. This review comprehensively assesses benefit b-blockers a part complete management
منابع مشابه
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
OBJECTIVE To clarify whether any particular β blocker is superior in patients with heart failure and reduced ejection fraction or whether the benefits of these agents are mainly due to a class effect. DESIGN Systematic review and network meta-analysis of efficacy of different β blockers in heart failure. DATA SOURCES CINAHL(1982-2011), Cochrane Collaboration Central Register of Controlled T...
متن کاملAntiproliferative effects of β-blockers on human colorectal cancer cells.
Colon cancer is the fourth and third most common cancer, respectively in men and women worldwide and its incidence is on the increase. Stress response has been associated with the incidence and development of cancer. The catecholamines (CA), adrenaline (AD) and noradrenaline (NA), are crucial mediators of stress response, exerting their effects through interaction with α- and β-adrenergic recep...
متن کاملTitrimetric and Spectrophotometric Methods for the Determination of β-blockers in Pharmaceutical Dosage Form
Three new methods using titrimetric and spectrophotometry are described for the determination of Propranolol Hydrochloride (PPH) and Atenolol (AN) with potassium bromate as the oxidimetric reagent and acid dyes, Methyl orange and Indigo carmine. In direct titrimetric (method A), the drug is titrated directly with bromate in acid medium and in the presence of excess of bromide using methyl orang...
متن کاملβ-blockers for COPD inpatients.
For clinicians who treat patients with respiratory diseases, the use of β-blockers has, for a long time, posed a dilemma because of the potential risk of bronchospasm and neutralisation of the effectiveness of β-2 agonists. This predicament is particularly challenging for patients with chronic obstructive pulmonary disease (COPD), many of whom have substantial cardiovascular comorbidity, and in...
متن کاملβ blockers in hypertension and cardiovascular disease
β blockers are useful in managing angina and reducing mortality after myocardial infarction and in heart failure. They probably reduce cardiovascular events in high risk surgery and retard the progression of atherosclerosis. In younger patients, β blockers should remain first line antihypertensives, together with diuretics, calcium channel blockers, angiotensin converting enzymes, and adrenergi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology in Clinical Practice
سال: 2023
ISSN: ['2450-1654', '2450-6478']
DOI: https://doi.org/10.5603/ocp.2022.0016